Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway

35Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

To determine the potential for differential release of islet amyloid polypeptide and insulin, we performed studies in rat islet monolayer cultures under conditions known to impair regulated beta-cell secretion. In inhibiting concentrations of epinephrine or the absence of calcium, islet amyloid polypeptide was secreted through a constitutive pathway while insulin was not. These findings suggest a mechanism for persistent islet amyloid polypeptide secretion and amyloid accumulation when regulated insulin release is impaired as in Type 2 (non-insulin-dependent) diabetes mellitus and insulinomas. © 1993 Springer-Verlag.

Cite

CITATION STYLE

APA

Kahn, S. E., Verchere, C. B., D’Alessio, D. A., Cook, D. L., & Fujimoto, W. Y. (1993). Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway. Diabetologia, 36(6), 570–573. https://doi.org/10.1007/BF02743276

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free